MYX 2.39% $4.50 mayne pharma group limited

Ann: Non-Executive Director retirement, page-13

  1. 1,386 Posts.
    lightbulb Created with Sketch. 265
    I think we may find they don’t have the funds
    after analysing the sales and marketing costs
    of Nextellis and our other recently acquired
    products . The 2019 deal we did with Mithra
    has almost broken the company.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.